JICA (Japan International Cooperation Agency)
The Japanese pharmaceutical industry is working with the Japan International Cooperation Agency (JICA), an affiliate of the Ministry of Foreign Affairs of Japan, to promote the "BOP Business Partnership" program, which encourages Japanese companies to participate in "BOP business" to solve the problems of the poor (BOP: Base of Pyramid) in developing countries, and to provide technical guidance to Japanese private companies to utilize their excellent products, technologies, and systems for the social and economic development of developing countries. The program also provides technical guidance to Japanese private-sector companies so that their excellent products, technologies, and systems can be utilized in the social and economic development of developing countries.
Promotion of BOP Business Collaboration
TAKEDA PHARMACEUTICAL COMPANY LIMITED
| Eligible Countries |
Project name |
Project Summary |
| Kenya |
Preparatory Survey for the Project for Improving Access to Medicines |
To improve access to medicines for the BOP in Kenya, where the diagnosis and treatment rates of non-communicable diseases are low, the project aims to establish a mechanism to sell medicines to MOP and TOP, and at the same time, to use the proceeds to subsidize medicines for the BOP and donate the products. |
Eisai Co., Ltd.
| Eligible Countries |
Project name |
Project Summary |
| Indonesia |
Preparatory survey for halal medicine business |
A survey on market needs, distribution, regulations, and assurance of halal quality of raw materials to supply halal-approved medicines to the BOP in Indonesia, where about 90% of the population is Muslim. |
Project for Promotion of Private Sector Technology for Socio-Economic Development in Developing Countries Health and Medical Care Special Framework
OTSUKA PHARMACEUTICAL Co., Ltd.
| Eligible Countries |
Project name |
Project Summary |
| Indonesia |
Project for Promotion of Adherence Support System for Tuberculosis Patients |
To develop a smartphone application for tuberculosis patients to support adherence to medication regimen and conduct demonstration tests at local hospitals to promote dissemination and understanding of the usefulness of the product among the Ministry of Health. |
TOP
